AAVantgarde Closes €61 Million Series A Financing to Advance Two Therapeutic Programs into the Clinic - Financing led by Atlas Venture and Forbion - Company created, incubated and seed financed by Sofinnova Partners MILAN, Italy, June 06, 2023 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a...

Forbion announces first close of Forbion Growth Opportunities Fund II at €470 million Forbion announces first close of Forbion Growth Opportunities Fund II at €470 million New fund to invest in late-stage European life sciences companiesInvestors include Pantheon, pension funds PME...

ARMGO Pharma raises $35 million to progress clinical studies of lead molecule ARM210 in cardiac and skeletal muscle diseases ARMGO Pharma raises $35 million to progress clinical studies of lead molecule ARM210 in cardiac and skeletal muscle diseases Series B investment led by Forbion and joined by Pontifax and Kurma...